Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2002 Mar;92(3):365-6.
doi: 10.2105/ajph.92.3.365.

Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies

Jeffrey S A Stringer  1 , Moses Sinkala, Dwight J Rouse, Robert L Goldenberg, Sten H Vermund
Affiliations
Comparative Study

Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies

Jeffrey S A Stringer et al. Am J Public Health. 2002 Mar.

Abstract

Objectives: This study evaluated the validity of concerns about the toxicity of nevirapine (NVP) that have delayed its implementation as a perinatal HIV prevention strategy.

Methods: A decision analysis model compared 3 strategies: single-dose NVP, short-course zidovudine (ZDV), and no intervention.

Results: NVP would prevent more deaths than ZDV and no intervention as long as the rate of NVP toxicity did not exceed, respectively, 9 times that observed in the earlier NVP clinical trial and 42 times that observed in the clinical trial. NVP would be economically preferable to ZDV as long as the rate of toxicity did not exceed 22 times that observed in the clinical trial.

Conclusions: Field implementation of NVP should not be delayed by concerns about its toxicity.

PubMed Disclaimer

References

    1. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795–802. - PubMed
    1. Campa AM, Shor-Posner G, Baum MK. HIVNET nevirapine trials [letter]. Lancet. 1999;354:1816.
    1. Marseille E, Kahn J, Mmiro F, et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999;354:803–809. - PubMed
    1. Stringer J, Rouse D, Vermund S, Goldenberg R, Sinkala M, Stinnett A. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J AIDS. 2000;24:369–377. - PubMed
    1. Dabis F, Msellati P, Meda N, et al. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet. 1999;353:786–792. - PubMed

MeSH terms